GeneChem is a manager of focused biotechnology
venture
capital funds. We have over $350M in assets
distributed
over
four funds: GeneChem Technologies,
GeneChem
Therapeutics,
Agechem and AmorChem.
Since 1997,
GeneChem has been
active in investing in
companies involved
in drug discovery and
development.
Together, we have
invested in over 60 companies located
in the US, Canada and
Europe. Today, GeneChem has
established itself as a leader in the management of
focused
biotech funds.
At GeneChem, we believe a successful deal combines
innovative
science, insightful management and collaborative
investor syndicate.